AU6242294A - 3,3-disubstituted tri- and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders - Google Patents
3,3-disubstituted tri- and tetracyclic indolin-2-ones useful for the treatment of cognitive disordersInfo
- Publication number
- AU6242294A AU6242294A AU62422/94A AU6242294A AU6242294A AU 6242294 A AU6242294 A AU 6242294A AU 62422/94 A AU62422/94 A AU 62422/94A AU 6242294 A AU6242294 A AU 6242294A AU 6242294 A AU6242294 A AU 6242294A
- Authority
- AU
- Australia
- Prior art keywords
- indolin
- tetracyclic
- disubstituted
- tri
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
- C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
- C07D513/06—Peri-condensed systems
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US96052292A | 1992-10-13 | 1992-10-13 | |
US960522 | 1992-10-13 | ||
PCT/US1993/009476 WO1994009009A1 (en) | 1992-10-13 | 1993-10-12 | 3,3-disubstituted tri- and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders |
Publications (1)
Publication Number | Publication Date |
---|---|
AU6242294A true AU6242294A (en) | 1994-05-09 |
Family
ID=25503278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU62422/94A Abandoned AU6242294A (en) | 1992-10-13 | 1993-10-12 | 3,3-disubstituted tri- and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0664810A1 (en) |
JP (1) | JPH08502293A (en) |
AU (1) | AU6242294A (en) |
CA (1) | CA2146000A1 (en) |
IL (1) | IL107251A0 (en) |
MX (1) | MX9306337A (en) |
WO (1) | WO1994009009A1 (en) |
ZA (1) | ZA937604B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112624972A (en) * | 2019-09-24 | 2021-04-09 | 中国人民解放军军事科学院军事医学研究院 | Acridone compound and medical application thereof |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5173489A (en) * | 1986-04-10 | 1992-12-22 | The Dupont Merck Pharmaceutical Co. | α,α-disubstituted aromatics and heteroaromatics as cognition enhancers |
US4760083A (en) * | 1986-04-10 | 1988-07-26 | E. I. Dupont De Nemours & Company | 3,3-disubstituted indolines |
US5278045A (en) * | 1990-02-28 | 1994-01-11 | Du Pont Merck Pharmaceutical Company | Method and compositions to screen compounds for enhancement of the cholinergic, dopaminergic and serotonergic function |
-
1993
- 1993-10-12 AU AU62422/94A patent/AU6242294A/en not_active Abandoned
- 1993-10-12 EP EP93923238A patent/EP0664810A1/en not_active Withdrawn
- 1993-10-12 MX MX9306337A patent/MX9306337A/en unknown
- 1993-10-12 JP JP6510082A patent/JPH08502293A/en active Pending
- 1993-10-12 CA CA002146000A patent/CA2146000A1/en not_active Abandoned
- 1993-10-12 IL IL107251A patent/IL107251A0/en unknown
- 1993-10-12 WO PCT/US1993/009476 patent/WO1994009009A1/en not_active Application Discontinuation
- 1993-10-13 ZA ZA937604A patent/ZA937604B/en unknown
Also Published As
Publication number | Publication date |
---|---|
WO1994009009A1 (en) | 1994-04-28 |
IL107251A0 (en) | 1994-01-25 |
EP0664810A1 (en) | 1995-08-02 |
JPH08502293A (en) | 1996-03-12 |
MX9306337A (en) | 1995-01-31 |
CA2146000A1 (en) | 1994-04-28 |
ZA937604B (en) | 1995-04-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU4088893A (en) | Processes for producing 1,1,1,2,3-pentafluoropropene and producing -pentafluoropropane | |
AUPM864894A0 (en) | Treatment of bowel-dependent neurological disorders | |
AU6112896A (en) | Tyrphostin-like compounds for the treatment of cell prolifer ative disorders or cell differentiation disorders | |
AU7545594A (en) | Implantable device for the treatment of aedemas | |
EP0582930A3 (en) | Process for the preparation of diarylcarbonates | |
AU3548795A (en) | Benzopyranopyrazolyl derivatives for the treatment of inflammation | |
AU1173195A (en) | Treatment of immunoregulatory disorders | |
AU4856893A (en) | 3,3'-disubstituted-1,3-dihydro-2h-pyrrolo{2,3-b}heterocyclic -2-one useful in the treatment of cognitive disorders of man | |
AU4619893A (en) | Substituted phenols, processes for their preparation and their use for the treatment of disorders caused by cell proliferation | |
AU7310896A (en) | Use of nitroflavonoids for the treatment of anxiety | |
AU6927894A (en) | 4-amidinophenylsulphonamides for the treatment of thrombo-embolitic conditions | |
AU3213593A (en) | Process for the preparation of 1,1,1,2-tetrafluoroethane | |
AUPM456894A0 (en) | Treatment for gastric disorders | |
ZA931063B (en) | Treatment of glaucoma. | |
EP0557949A3 (en) | Process for the preparation of 2,4,5 trifluorobenzonitrile | |
AU4081393A (en) | Medicaments for the treatment of anxiety | |
AU5371694A (en) | Use of the tarchonanthus camphoratus | |
AU5430894A (en) | Diagnosis of eye disorders | |
AU6242294A (en) | 3,3-disubstituted tri- and tetracyclic indolin-2-ones useful for the treatment of cognitive disorders | |
AU6581294A (en) | Ethanolamine derivatives useful for the treatment of gastrointestinal disorders | |
AU4096789A (en) | The use of lactam derivatives in the treatment of cognitive disorders | |
EP0583136A3 (en) | Piperidino-3,4-dihydrocarbostyryl compounds for the treatment of ischemic disorders | |
AU3419793A (en) | Method of diagnosing combined cognitive/debilatory disorders | |
AU5066693A (en) | Process for the preparation of 5,6-diacetoxyindole | |
AU664118B2 (en) | Process for the agrochemical treatment of grasslands |